PHILADELPHIA, PA, USA (UroToday.com) - This was a post hoc analysis of solifenacin Efficacy and Safety in Patients with Urgency Study (VENUS) to determine patients with severe OAB symptoms at baseline.
Your session will expire in 8 hours requiring you to log in each day to view content.


